These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 4001891

  • 1. Sequential studies of complement activation in systemic lupus erythematosus.
    Sturfelt G, Johnson U, Sjöholm AG.
    Scand J Rheumatol; 1985; 14(2):184-96. PubMed ID: 4001891
    [Abstract] [Full Text] [Related]

  • 2. Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.
    Jonsson H, Sturfelt G, Mårtensson U, Truedsson L, Sjöholm AG.
    Clin Exp Rheumatol; 1995; 13(5):573-80. PubMed ID: 8575134
    [Abstract] [Full Text] [Related]

  • 3. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
    Jonsson H, Sjöholm AG, Mårtensson U, Laurell AB, Sturfelt G.
    Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
    [Abstract] [Full Text] [Related]

  • 4. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
    Sturfelt G, Sjöholm AG.
    Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
    [Abstract] [Full Text] [Related]

  • 5. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G, Sjöholm AG, Svensson B.
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.
    Swaak AJ, Groenwold J, Hannema A, Hack CE.
    Rheumatol Int; 1985; 5(5):215-20. PubMed ID: 3877968
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A, Barr SG, Magder LS, Petri M.
    Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
    [Abstract] [Full Text] [Related]

  • 14. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
    Lockshin MD, Qamar T, Redecha P, Harpel PC.
    Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus.
    Raymond W, Eilertsen G, Nossent J.
    J Immunol Res; 2018 Dec; 2018():8051972. PubMed ID: 30687766
    [Abstract] [Full Text] [Related]

  • 19. Complement activation in patients with systemic lupus erythematosus without nephritis.
    Mollnes TE, Haga HJ, Brun JG, Nielsen EW, Sjöholm A, Sturfeldt G, Mårtensson U, Bergh K, Rekvig OP.
    Rheumatology (Oxford); 1999 Oct; 38(10):933-40. PubMed ID: 10534542
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.